Results 191 to 200 of about 17,075 (245)

Gavi's Zero-Dose Learning Hubs: enhanced approach for evidence generation and use from local to global. [PDF]

Health Policy Plan
Reynolds HW, Corrêa GC, Vollmer N, Broekhuysen E, Saville E, Hogan D, Johnson HL.   +6 more
europepmc   +1 more source

Bridging Policy Gaps in Transition Times: How Local Actors Navigate Low Policy Coherence for Advancing a Circular Built Environment

Environmental Policy and Governance, EarlyView.
ABSTRACT The construction sector is a major contributor to the climate crisis, accounting for over one‐third of global energy‐related CO2 emissions. In response, the European Commission identified the circular economy as a means of achieving green growth and prioritized the construction sector in its Circular Economy Action Plan.
A. (Angeline) Chartier, W. D. (Wieke) Pot   +1 more
wiley   +1 more source

Predictive factors of successful renal replacement therapy weaning : Deciding On patients Orientations after Renal replacement therapy Stopping (The DOORS study). [PDF]

Intensive Care Med
Chaïbi K, Akrour Y, Louis G, Lefevre LM, Pons B, Moschietto S, Boulet E, Hajage D, Lebbah S, Quenot JP, Sangla F, Dreyfuss D, Gaudry S, Legouis D, DOORS investigators.   +14 more
europepmc   +1 more source

How Multiple Streams Influence Agenda‐Setting for Water Reuse in Swiss Substates

Environmental Policy and Governance, EarlyView.
ABSTRACT As climate change creates significant challenges for both the environment and society, potential mitigation and adaptation solutions are widely discussed. Yet, neither challenges nor their potential solutions automatically reach the political agenda or lead to a policy decision.
Magdalena A. Knabl, Katrin Pakizer, Manuel Fischer, Eberhard Morgenroth, Christian Binz   +4 more
wiley   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Bridging glucose metabolism and intrinsic functional organization of the human cortex. [PDF]

Commun Biol
Wan B, Riedl V, Castrillon G, Kirschner M, Valk SL.   +4 more
europepmc   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source

Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology. [PDF]

J Glob Health
Sá Silva S, Ko M, Cherian T, Qazi S, Chang Blanc D, Mvundura M, Morgan C, Kochhar S, Suwantika A, Innis B, Kretsinger K, Crowcroft N, Jarrahian C, Thorson A, Vahedi M, Efe-Aluta O, Mistilis JJ, Giersing B, Hasso-Agopsowicz M.   +18 more
europepmc   +1 more source

Educating for environmental transition: the summer school on microplastics. [PDF]

Environ Sci Pollut Res Int
Slaveykova VI, Andersen TJ, Błasiak T, Cararo A, Marelja M, Parolini M, Posth NR, Siaussat D, Sorrentino L.   +8 more
europepmc   +1 more source

Correction: Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials. [PDF]

Front Antibiot
DiNardo AR, Sabiiti W, Gillespie SH, Georghiou SB, Heinrich N, Hittel N, Taghlabi S, Longlax DC, Kohli M, Panzner U, Musia C, Lange C, Vasiliu A, Arts RJW, Mandalakas AM, Ruhwald M, Stuyver LJ, van Crevel R.   +17 more
europepmc   +1 more source